-
1 week ago | 
marketingdive.com | Peter Adams |Julia Himmel
As brands enter the thick of the annual season for brokering advertising commitments, also known as the upfronts, many are in a disquietingly familiar state of uncertainty. The Trump administration’s trade war has upended 2025 planning, putting marketers in a holding pattern and potentially pushing more toward cheaper, lower-funnel channels.
-
Nov 21, 2024 | 
biopharmadive.com | Gwendolyn Wu |Ben Fidler |Ned Pagliarulo |Julia Himmel
Drug development is an expensive, risky endeavor. Biotechnology companies just starting out are many years away from seeing profits, if ever. So more often than not, a startup’s success turning science into medicines can come down to how much money it raises. That’s where venture capitalists step in, investing many millions of dollars for stakes in newly formed companies.
-
Nov 5, 2024 | 
manufacturingdive.com | Kate Magill |Julia Himmel |Diana DiGangi |Sarah Zimmerman
Today’s the day. Voters are heading to the polls to decide the next president, who will lead the country in shaping the next era of U.S. manufacturing. Both Vice President Kamala Harris and former President Donald Trump say they’re committed to building the industry and its workforce in the coming years, with different strategies to do so.
-
Oct 28, 2024 | 
buchalter.com | Ryan Golden |Julia Himmel
EEOC wants to collect pay data again. It might have an easier path to do soBy: Ryan Golden and Julia Himmel“More than half a decade ago, the nation’s top workplace civil rights enforcement agency began a high-level examination of how U.S. employers paid their employees, an experiment it said was intended to measure the nation’s level of pay inequity. ‘From an employer’s perspective, there’s going to be more and more focus placed on pay disparities,’ Hinckley said.
-
Oct 25, 2024 | 
hrdive.com | Ryan Golden |Julia Himmel
More than half a decade ago, the nation’s top workplace civil rights enforcement agency began a high-level examination of how U.S. employers paid their employees, an experiment it said was intended to measure the nation’s level of pay inequity. The collection, known as the U.S. Equal Employment Opportunity Commission’s 2017 and 2018 EEO-1 Component 2, did not sit well with all constituencies.
-
Oct 8, 2024 | 
pharmavoice.com | Julia Himmel
The pharma industry is always transforming. Scientific and business advances build on achievements from the past, and major breakthroughs reshape the market. Behind the many changes of the last year are the leaders that drive that transformation, and their advances have been prolific. GLP-1 agonists once primarily used for diabetes shifted to obesity and found runaway success. Advances in gene therapies paved the way to the approval of the first gene editing CRISPR drug.
-
Sep 24, 2024 | 
manufacturingdive.com | Kate Magill |Julia Himmel
Manufacturers are pouring money into this election cycle.
Manufacturing-related political action committees have donated more than $24.9 million to political campaigns so far this cycle, as of Sept. 23, according to OpenSecrets, a nonprofit that tracks and publishes U.S. political donation data.
-
Aug 16, 2024 | 
manufacturingdive.com | Kate Magill |Julia Himmel |Eric Walz |Haley Cawthon
It’s been two years since President Joe Biden signed the landmark Inflation Reduction Act into law. The sweeping legislation is a key tenet of the Biden administration’s plan to usher in a new age of clean energy manufacturing in the U.S. through a bevy of federal grants, tax credits and other incentives meant to entice companies to invest in domestic production.
-
May 15, 2024 | 
manufacturingdive.com | Kate Magill |Julia Himmel
Across the U.S., companies continue to invest billions of dollars in clean manufacturing projects as they pursue lucrative tax credits offered under the Inflation Reduction Act. The law, passed in August 2022, has helped spur a new era in U.S. manufacturing, with factories popping up in dozens of states to produce items such as electric vehicles, batteries and solar panels.
-
Apr 4, 2024 | 
cfodive.com | Ryan Golden |Shaun Lucas |Julia Himmel
When Seattle Children’s Hospital began laying the foundation for its next 20 years of growth, it needed to address an issue seemingly tangential to its mission: what to do about all the cars. That growth planning began in 2010. Advancements in patient care had improved health outcomes but also meant the hospital would need to double in size to accommodate increased demand for long-term care.
